文献速递物质与行为成瘾

可卡因使用障碍中痛敏肽受体上调:一项[11C]NOP-1A正电子发射断层成像研究

Nociceptin Receptors Upregulated in Cocaine Use Disorder: A Positron Emission Tomography Imaging Study Using [11C]NOP-1A.
PubMed 文献 · Am J Psychiatry · 2019-05-06

该研究采用[11C]NOP-1A PET测量24例可卡因使用障碍者(戒断2周)与26名健康对照的NOP受体结合,发现患者组全脑感兴趣区VT普遍增加约10%,中脑、腹侧纹状体和小脑最明显,但未预测12周随访复发。

要点

  • 可卡因使用障碍者戒断2周后脑内NOP受体结合普遍上调约10%。
  • 上调在中脑、腹侧纹状体和小脑最突出,但未预测复发。
  • NOP上调可能反映N/OFQ下降或CRF传递增强的代偿适应。

核心结论

  • 可卡因使用障碍者脑内NOP受体结合较健康对照普遍增加约10%,提示对N/OFQ减少或CRF传递增强的代偿适应。

研究设计与样本

  • 研究使用[11C]NOP-1A PET测量24例无共病精神或躯体疾病的可卡因使用障碍者(门诊监控戒断2周后)与26名年龄、性别和吸烟状态匹配的健康对照的体内NOP结合。
  • 采用动脉输入函数动力学分析测量脑内感兴趣区[11C]NOP-1A分布容积(VT),并对患者随访12周记录复发。

主要发现

  • 可卡因使用障碍组较健康对照组[11C]NOP-1A VT显著增加,增加遍及所有感兴趣区(约10%)。
  • VT增加在中脑、腹侧纹状体和小脑最突出。
  • 这些区域的VT增加未预测复发。

临床怎么用

  • NOP受体上调支持探索增强N/OFQ的NOP激动剂药物治疗可卡因使用障碍。
  • 未来需研究CRF与NOP交互作用以阐明其在负性强化和复发中的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Nociceptin/orphanin FQ (N/OFQ) is an antistress neuropeptide transmitter in the brain that counteracts corticotropin-releasing factor (CRF)-mediated stress and anxiety symptoms during drug and alcohol withdrawal. It also inhibits the release of a wide array of neurotransmitters, including dopamine and glutamate, which allows for it to block the rewarding properties of cocaine. Chronic cocaine administration in rodents has been shown to decrease N/OFQ and increase nociceptive opioid peptide (NOP) receptors in the nucleus accumbens. No previous studies have reported on the in vivo status of NOP in chronic cocaine-abusing humans. METHODS: [11C]NOP-1A and positron emission tomography (PET) were used to measure in vivo NOP binding in 24 individuals with cocaine use disorder and 26 healthy control subjects matched for age, sex, and smoking status. Participants with cocaine use disorder with no comorbid psychiatric or medical disorders were scanned after 2 weeks of outpatient-monitored abstinence. [11C]NOP-1A distribution volume (VT) was measured with kinetic analysis using the arterial input function in brain regions that mediate reward and stress behaviors. Participants with cocaine use disorder were followed up for 12 weeks after PET scanning to document relapse and relate it to VT. RESULTS: A significant increase in [11C]NOP-1A VT was observed in the cocaine use disorder group compared with the healthy control group. This increase, which was generalized across all regions of interest (approximately 10%), was most prominent in the midbrain, ventral striatum, and cerebellum. However, increased VT in these regions did not predict relapse. CONCLUSIONS: Increased NOP in cocaine use disorder suggests an adaptive response to decreased N/OFQ, or increased CRF transmission, or both. Future studies should examine the interactions between CRF and NOP to elucidate their role in negative reinforcement and relapse. NOP agonist medications to enhance N/OFQ should be explored as a therapeutic to treat cocaine use disorder.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Narendran R, Tollefson S, Himes ML, et al. Nociceptin Receptors Upregulated in Cocaine Use Disorder: A Positron Emission Tomography Imaging Study Using [11C]NOP-1A. Am J Psychiatry. 2019. PMID: 31055968. doi:10.1176/appi.ajp.2019.18081007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。